Home » All » Stock Forecast » NewAmsterdam Pharma Company N.V. Ordinary Shares Forecast

NewAmsterdam Pharma Company N.V. Ordinary Shares Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -3.96%Market Cap $3.73B · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$32.94 ▲ +1.41%	Yesterday	$32.29 ▼ -0.59%	Tomorrow's NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) setup is anchored to $32.48 and targets $32.94 (+1.41%). The near-term read is upside; watch $33.45 / $31.51 because daily realized volatility is about 7.29%.
Tomorrow's NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) setup is anchored to $32.48 and targets $32.94 (+1.41%). The near-term read is upside; watch $33.45 / $31.51 because daily realized volatility is about 7.29%.
Week	$33.91 ▲ +4.40%	Last Week	$31.88 ▼ -1.85%	The 7-day NewAmsterdam Pharma Company N.V. Ordinary Shares model moves from $31.88 to $33.91 (+4.40%). It gives upside momentum context for this stock, so breaks around $33.45 / $31.51 matter more than a single tick.
The 7-day NewAmsterdam Pharma Company N.V. Ordinary Shares model moves from $31.88 to $33.91 (+4.40%). It gives upside momentum context for this stock, so breaks around $33.45 / $31.51 matter more than a single tick.
Month	$35.52 ▲ +9.37%	Last Month	$31.20 ▼ -3.94%	The 1-month NewAmsterdam Pharma Company N.V. Ordinary Shares target is $35.52 (+9.37%), compared with the live reference near $32.48. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month NewAmsterdam Pharma Company N.V. Ordinary Shares target is $35.52 (+9.37%), compared with the live reference near $32.48. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$37.94 ▲ +16.82%	Last Year	$30.19 ▼ -7.07%	The 1-year NewAmsterdam Pharma Company N.V. Ordinary Shares scenario points to $37.94 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year NewAmsterdam Pharma Company N.V. Ordinary Shares scenario points to $37.94 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$43.62 ▲ +34.29%	5 Years Ago	$27.80 ▼ -14.40%	The 5-year NewAmsterdam Pharma Company N.V. Ordinary Shares view is $43.62 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year NewAmsterdam Pharma Company N.V. Ordinary Shares view is $43.62 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$32.94▲ +1.41%

Yesterday$32.29▼ -0.59%

Tomorrow's NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) setup is anchored to $32.48 and targets $32.94 (+1.41%). The near-term read is upside; watch $33.45 / $31.51 because daily realized volatility is about 7.29%.

Week$33.91▲ +4.40%

Last Week$31.88▼ -1.85%

The 7-day NewAmsterdam Pharma Company N.V. Ordinary Shares model moves from $31.88 to $33.91 (+4.40%). It gives upside momentum context for this stock, so breaks around $33.45 / $31.51 matter more than a single tick.

Month$35.52▲ +9.37%

Last Month$31.20▼ -3.94%

The 1-month NewAmsterdam Pharma Company N.V. Ordinary Shares target is $35.52 (+9.37%), compared with the live reference near $32.48. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$37.94▲ +16.82%

Last Year$30.19▼ -7.07%

The 1-year NewAmsterdam Pharma Company N.V. Ordinary Shares scenario points to $37.94 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$43.62▲ +34.29%

5 Years Ago$27.80▼ -14.40%

The 5-year NewAmsterdam Pharma Company N.V. Ordinary Shares view is $43.62 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$32.48	Mid
Daily Change	-3.96%	Below
Volatility Cap	20.0%	Mid
Confidence	66%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$32.48

Daily Change-3.96%

Market Cap$3.73B

Sourcenasdaq-screener

Current	$32.48	Daily Change	-3.96%
Market Cap	$3.73B	Source	nasdaq-screener

Support & Resistance Levels

$31.51Support 1

$32.48Current

$33.45Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$32.48Live reference price

Used as the anchor for generated forecast calculations.

Next Month$35.52Model projection+9.37%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

66%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

66%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in NAMS today

Bullish Scenario

$34.10

+5.00% from current

Target Price$34.10

ScenarioUpside momentum

Probability58%

Base Scenario

$35.52

+9.37%

Target Price$35.52

ScenarioCapped drift

Probability66%

Bearish Scenario

$30.86

-5.00% from current

Target Price$30.86

ScenarioVolatility drawdown

Probability34%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 70/100

24H drift+1.41%

7D drift+4.40%

30D drift+9.37%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 67/100

1M outlook+9.37%

1Y outlook+16.82%

5Y outlook+34.29%

Frequently Asked Questions

Q What is the NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), NewAmsterdam Pharma Company N.V. Ordinary Shares is projected near $32.94 versus the current reference around $32.48. That implies a modeled move of +1.41% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for NAMS?

The weekly NewAmsterdam Pharma Company N.V. Ordinary Shares model points to $33.91, which maps to an expected drift of +4.40% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the NewAmsterdam Pharma Company N.V. Ordinary Shares 1-month and 1-year targets?

The NewAmsterdam Pharma Company N.V. Ordinary Shares 1-month target is $35.52 (+9.37%), while the 1-year target is $37.94 (+16.82%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the NewAmsterdam Pharma Company N.V. Ordinary Shares 5-year scenario differ from short-term rows?

The NewAmsterdam Pharma Company N.V. Ordinary Shares long-horizon scenario sits near $43.62 with a modeled change of +34.29%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are NAMS support and resistance zones right now?

For NewAmsterdam Pharma Company N.V. Ordinary Shares, nearest resistance is around $31.51, while nearest support is around $33.45. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the NewAmsterdam Pharma Company N.V. Ordinary Shares market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.